Osilodrostat(LCI699) phosphate
98%
- Product Code: 62542
CAS:
1315449-72-9
| Molecular Weight: | 325.23 g./mol | Molecular Formula: | C₁₃H₁₀FN₃H₃O₄P |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
Osilodrostat phosphate is primarily used in the treatment of Cushing's syndrome, a condition caused by excessive cortisol production in the body. It works by inhibiting the enzyme 11β-hydroxylase, which is crucial in the synthesis of cortisol in the adrenal glands. By blocking this enzyme, the drug effectively reduces cortisol levels, helping to alleviate symptoms such as weight gain, high blood pressure, and glucose intolerance. It is particularly beneficial for patients who are not suitable candidates for surgery or have not responded adequately to other treatments. The phosphate form enhances its solubility and bioavailability, making it more effective for oral administration. Clinical studies have shown its efficacy in normalizing cortisol levels and improving the overall quality of life for patients with this challenging condition.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | £1,071.71 |
+
-
|
Osilodrostat(LCI699) phosphate
Osilodrostat phosphate is primarily used in the treatment of Cushing's syndrome, a condition caused by excessive cortisol production in the body. It works by inhibiting the enzyme 11β-hydroxylase, which is crucial in the synthesis of cortisol in the adrenal glands. By blocking this enzyme, the drug effectively reduces cortisol levels, helping to alleviate symptoms such as weight gain, high blood pressure, and glucose intolerance. It is particularly beneficial for patients who are not suitable candidates for surgery or have not responded adequately to other treatments. The phosphate form enhances its solubility and bioavailability, making it more effective for oral administration. Clinical studies have shown its efficacy in normalizing cortisol levels and improving the overall quality of life for patients with this challenging condition.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :